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Abstract 
 
A convenient and efficient approach to 2-arylamino-5-fluoroalkyl-1,3,4-oxadiazoles has 
been established via heterocyclization of corresponding di- and trifluoroacetylated 
thiosemicarbazides by treatment with dicyclohexylcarbodiimide (DCC). Another 
heterocyclization performed with selected thiosemicarbazides under basic conditions led 
to 4-aryl-5-fluoroalkyl-2,4-dihydro-3H-1,2,4-triazole-3-thiones in moderate yields. As a 
precondition for these transformations, a smooth preparation of the fluoroacetylated 
thiosemicarbazides via fluoroacetylation of benzyloxycarbonyl (Cbz)-protected 
hydrazine with a corresponding anhydride, followed by hydrogenolytic deprotection and 
reaction with arylisothiocyanates has been elaborated. Similarly, fluoroacetylated 
semicarbazides were prepared, but all attempts to achieve their heterocyclization were 
unsuccessful. 
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1. Introduction 
Fluorinated heterocycles are widely applied as biologically active compounds for the 
preparation of new drugs, agrochemicals and materials with special properties [1]. The 
development of methods for stereoselective syntheses of diverse fluorinated N-
heterocycles is also of current interest [2]. Among heterocyclic systems which attract 
great attention, an important class comprises 1,3,4-oxadiazole derivatives [3] including 
fluorinated examples [4]. 
Hydrazides of carboxylic acids (carbohydrazides) are known as versatile building 
blocks used for the preparation of heterocyclic compounds with diverse ring size. Target 
heterocycles can be synthesized starting either with substituted carbohydrazides or their 
derivatives such as hydrazones, semicarbazides, thiosemicarbazides, etc. [5]. A known 
method for the preparation of 1,3,4-oxadiazoles is the treatment of semicarbazides 
derived from carbohydrazides with sulfuric acid [6] or another acidic agent. 
Alternatively, they can be obtained directly from carbohydrazides via the reaction with 
orthoesters [7]. 
Due to our continuing interest in the development of methods for the synthesis of 
fluorinated heterocycles [8], we focused attention on the exploration of the relatively 
little known trifluoro- and difluoroacetyl hydrazides (1a, b) as potential precursors for 
the preparation of fluorinated 1,3,4-oxadiazoles. The method selected for the synthesis 
of the latter was heterocyclization of semicarbazides of fluorinated carbohydrazides 
using sulfuric acid. In addition, analogous heterocyclizations should be performed 
starting with thiosemicarbazides and selenosemicarbazides in order to obtain the 
corresponding 1,3,4-thia- or 1,3,4-selenadiazoles. 
 
2. Results and discussion 
 
Typically, the access to carbohydrazides is based on the reaction of the corresponding 
carboxylic esters with an equimolar amount of hydrazine hydrate [5]. In our hands, 
treatment of methyl trifluoroacetate with 1–5.0 equivalents of hydrazine hydrate in 
methanolic solution led to bis(trifluoroacetyl)hydrazine (2a) as the product (Scheme 1). 
Its structure was confirmed by the ESI-MS registered for the crude product, which 
displayed a single signal for m/z 223.2. Increasing of the amount of hydrazine hydrate to 
1:10 or 1:20 resulted in a mixture of comparable amounts of 2a and 1a or in the 
exclusive formation of 1a, respectively. Apparently, the initially formed 1a reacts 
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rapidly with the starting ester yielding 2a as the final product. The formation of the 
analogous product 2b was observed using methyl difluoroacetate in the reaction with 
hydrazine hydrate. In the course of the attempted synthesis of 1a, the tested protocol 
with 20-fold excess of hydrazine hydrate was practically useless as the expected product 
could not be efficiently separated from the excess of hydrazine hydrate. In the light of 
the presented results, the reported syntheses of 1a from trifluoroacetates and hydrazine 
hydrate used in nearly equimolar amounts seem to be non-reproducible protocols [9]. 
However, instability of 1a was observed during the storage of the isolated product 
already at room temperature [9a].  
 
1a RF = CF3 2a
RF COOMe + H2NNH2 . H2O
MeOH
r.t. RF
O
NHNH2
1b RF = CHF2
RFCOOMe
HN NH
RF
OO
RF
2b
 
Scheme 1 
 
For that reason, the Boc- and Cbz-protected hydrazines 3a and 3b, respectively, were 
prepared and converted into the N-protected non-symmetrical trifluoro- and 
difluoroacetyl hydrazines 4a–4c by treatment with trifluoro- or difluoroacetic anhydride 
(Scheme 2). Similar approaches for the synthesis of 1a based on the application of N-
Boc protected hydrazine were only rarely reported [10]. 
 
3a R' = O tBu
3b R' = OBn
H2NHN
O
R'
+ (RFCO)2O
CH2Cl2
Et3N, 0oC HN NH
R'
OO
RF
4a R' = O tBu, RF = CF3
4c R' = OBn, RF = CHF2
4b R' = OBn, RF = CF3
 
Scheme 2 
 
However, in our hands, the attempted deprotection of the Boc-hydrazide 4a performed 
typically by treatment with trifluoroacetic acid in CH2Cl2 at 0 ºC or with HCl in dioxane 
at 0 ºC yielded exclusively the symmetrical 2a. On the other hand, hydrogenolysis of 4b 
and 4c over Pd/C in THF at room temperature afforded the desired trifluoro- and 
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difluoroacetyl hydrazides 1a and 1b, respectively, as sole products (Scheme 3). In the 
case of 1a, the attempted isolation led again to its conversion into the symmetrical 2a. 
Therefore, freshly prepared 1a and 1b in THF solution were treated with isocyanates, 
isothiocyanates and isoselenocyanates 5 (X = O, S, Se, resp., Scheme 3). The most 
reactive isocyanates 5 (X = O) formed the expected semicarbazides 6a–f (X = O) in 
high yields (Scheme 3, Table 1). Similarly, aromatic isothiocyanates 5 (X = S) gave 
thiosemicarbazides 6g–j (X = S) in good yields, and only in the case of the less reactive 
cyclohexylisothiocyanate the corresponding products 6k and 6l (X = S) were formed in 
low yields and could not be isolated in pure form. Finally, the attempted reactions of 
1a,b with phenyl isoselenocyanate led to black colored, complex mixtures of non-
identified products. 
 
1a,b 6
RF
O
NHNH2 HN NH
NHR
XO
RF4b or 4c
H2, Pd/C
THF, r.t.
R-NCX
5
THF, 0oC
 
Scheme 3 
 
Table 1. Prepared N-acylated semicarbazides and thiosemicarbazides 6. 
Hydrazide RF Reagent R X Product Yield (%)a 
1a CF3 5a Ph O 6a 88 
1a CF3 5b 4-FC6H4 O 6b 91 
1a CF3 5c 4-MeOC6H4 O 6c 86 
1a CF3 5d cHex O 6d 93 
1b CHF2 5a Ph O 6e 90 
1b CHF2 5d cHex O 6f 94 
1a CF3 5e Ph S 6g 77 
1a CF3 5f 4-FC6H4 S 6h 74 
1a CF3 5g 4-MeOC6H4 S 6i 68 
1b CHF2 5e Ph S 6j 80 
1a CF3 5h cHex S 6k ca. 30b 
1b CHF2 5h cHex S 6l ca. 30b 
 
a Yields of isolated products. 
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b Symmetrical N,N’-bis(trifluoroacetyl)hydrazine (2a) was formed as a by-product and 
separation of the mixture could not be achieved. Yields of 6k and 6l were estimated 
based on the registered MS spectra.  
 
First experiments aimed at the preparation of fluorinated 1,3,4-oxadiazoles were 
performed with 6a using ethyl orthoacetate and catalytic amounts of p-TsOH, but in this 
case a complex mixture of non-identified products was formed. Similarly, treatment of 
6a with conc. H2SO4 led to the same result. Finally, the reaction of thiosemicarbazides 
6g–j with DCC in boiling THF afforded selectively 2-amino-1,3,4-oxadiazoles 7a–d in 
excellent yields (Scheme 4, Table 2). Analytically pure products were isolated after 
flash column chromatography. Their structures were established by means of 
spectroscopic methods. For example, the 13C-NMR spectrum of 7a revealed a singlet for 
C(2) at 161.7 ppm and a quartet for C(5) with 2JC,F = 42.9 Hz at 147.9 ppm. The 
characteristic quartet with 1JC,F = 268.1 Hz at 116.8 ppm was attributed to the CF3 
group. In addition, the 19F-NMR spectrum showed the signal of the CF3 group at –
64.6ppm. 
 
6g-j
HN NH
NHR
SO
RF
DCC, THF
ref lux, 9h O
NN
NHRRF
7a-d  
Scheme 4 
 
Table 2. Synthesis of fluorinated 2-amino-1,3,4-oxadiazoles 7 via heterocyclization of 
acylated thiosemicarbazides 6. 
 
Thiosemicarbazide RF R 1,3,4-Oxadiazole Yield (%)a 
6g CF3 Ph 7a 92 
6h CF3 4-FC6H4 7b 95 
6i CF3 4-MeOC6H4 7c 80 
6j CHF2 Ph 7d 82 
 
a  Yield of isolated product. 
 
It is worth mentioning that an efficient access to 2-amino-1,3,4-oxadiazoles comprises 
the reaction of thiosemicarbazides of type 6 (X = S) with TsCl and pyridine [11]. In 
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some cases, the same product could be obtained from the corresponding semicarbazide, 
albeit in significantly lower yield and after longer reaction time. The reported formation 
of 7a as the exclusive product was confirmed also in our laboratory. 
In extension of the study, fluorinated thiosemicarbazides 6g and 6j were heated in a 
aqueous solution of NaOH (2%) and 1,2,4-triazole-3-thiones 8 were obtained in 
moderate yields (Scheme 5). This observation confirms the behavior of 
thiosemicarbazides under basic conditions [12]. Again, the attempted cyclization of 
corresponding semicarbazides 6 (X = O) under analogous conditions was unsuccessful. 
 
HN NH
NHPh
SO
RF
2% NaOH
reflux, 3h
N
NHN
SRF
8a RF = CF3 (34%)
8b RF = CHF2 (36%)
6g RF = CF3
6j RF = CHF2
Ph
 
Scheme 5 
 
3. Conclusions 
 
The present study showed that in addition to other methods for the preparation of 2-
amino-1,3,4-oxadiazoles based on the heterocyclization of semicarbazides, the 
corresponding thiosemicarbazides can also be used including fluorinated derivatives. 
The heterocyclization of fluorinated thiosemicarbazides can be efficiently performed 
using DCC as the activating and H2S-binding reagent. This protocol supplements the 
already reported method with p-TsCl and pyridine in THF solution [11]. In both 
procedures, the heterocyclization occurs chemoselectively via the conversion of the 
more nucleophilic C=S function into a good leaving group and the subsequent 
nucleophilic attack of the O-atom leading to 2-amino-1,3,4-oxadiazoles as final 
products. This type of chemoselectivity is preserved also in thiosemicarbazides 
containing an electron-deficient RFCO group. Another method for the synthesis of 
symmetrical 2,5-bis(perfluoroalkyl)-substituted 1,3,4-oxadiazoles from 1,2-
diacylhydrazines, prepared stepwise by two-fold acylation of hydrazine, is the 
cyclization by treatment with POCl3 as activating and dehydrating agent [9b]. This 
approach can be considered as a pioneering method for the synthesis of 1,3,4-
oxadiazoles [13]. 
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The presented method for the preparation of fluorinated 2-amino-1,3,4-oxadiazoles 
requires an efficient access to fluorinated monoacetylhydrazines. Our study showed that 
they can be synthesized from Cbz-protected hydrazine and the corresponding 
fluorinated acetanhydrides. After the deprotection, the obtained carbohydrazides have to 
be reacted immediately with isocyanates or isothiocyanates to give the required 
semicarbazides and thiosemicarbazides, respectively. Otherwise they undergo 
spontaneous disproportionation yielding symmetrical 1,2-diacylhydrazines, which are of 
limited importance for further applications. 
 
4. Experimental 
 
4.1. General information 
 
Melting points were determined on a Melt-Temp II apparatus (Aldrich) in 
capillaries, and they are uncorrected. The 1H, 13C{1H} and 19F NMR spectra were 
recorded on a Bruker Avance III 600 spectrometer using the solvent signal as reference. 
Assignments of signals in 13C NMR spectra were achieved using HMQC and HMBC 
techniques. IR spectra were measured using a NEXUS FT-IR spectrophotometer. The 
ESI-MS spectra were obtained using a Varian 500 MS LS Ion Trap spectrometer. 
Elemental analyses were recorded on Elementar Vario Micro Cube apparatus.  
 
4.2. Materials 
 
All solvents were used as commercial products. Methyl trifluoroacetate, methyl 
difluoroacetate, trifluoroacetic acid anhydride, and difluoroacetic acid anhydride, were 
purchased from Fluorochem. Chloroform was dried over phosphorus pentoxide (P2O5) 
and freshly distilled prior to use. Tetrahydrofuran (THF) was dried over sodium in the 
presence of benzophenone and freshly distilled from the violet-colored solution prior to 
use. Anhydrous ethanol was dried over calcium oxide and CH2Cl2 over calcium hydride. 
(tert-Butoxycarbonyl)hydrazine (3a) [14a] and (benzyloxycarbonyl)hydrazine (3b) 
[14b] were obtained according to the known protocols.  
 
4.3. Synthesis of the symmetrical N,N’-bis(trifluoroacetyl)hydrazine (2a).  
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Ethyl trifluoroacetate (142 mg, 1.0 mmol) was added dropwise to the solution of 
hydrazine hydrate (50 mg, 1.0 mmol) in MeOH (~5.0 ml). The reaction mixture was 
stirred over 1 h at room temperature. Next, the solvent was evaporated and the solid 
product was crystallized from EtOH.  
 
 
N,N’-Bis(trifluoroacetyl)hydrazine (2a): Yield 160 mg (71%), m.p. = 173–175 °C 
(EtOH), (lit. [9b], m.p. 176 °C). 1H NMR (600 MHz, DMSO-d6): δ 7.45 (br.s, 2H, 2 
NH). 13C NMR (150 MHz, DMSO-d6): δ 118.1 (q, 1JC,F = 284.4 Hz, 2 CF3), 159.1 (q, 
2JC,F = 31.0 Hz, 2 C=O). 19F NMR (565 MHz, DMSO-d6): δ –72.9 (s, 6F, 2 CF3). IR 
(KBr): ν 3346m, 3293w, 3213w, 3142w, 2989m, 2957w, 2858w, 2756w, 1612vs, 1520w, 
1414m, 1203vs, 1190vs, 1146vs, 1098s, 973m cm–1. HR-EI-MS: calcd. for C4H2F3N2O2+ 
(M+): m/z 224.00205; found: m/z 224.00128. 
 
4.4. Reactions of protected hydrazines 3a,b with fluorinated acids anhydrides – General 
procedure 
A solution of BocNHNH2 (3a, 3.0 mmol, 498 mg) or CbzNHNH2 (3b, 3.0 mmol, 396 
mg) in anhydrous CH2Cl2 (~30 ml) was placed in an ice-bath (~0 oC). Next, 
triethylamine (4.5 mmol, 455 mg) was added, and after ca. 20 min, the appropriate 
fluorinated anhydride (3.2 mmol) was added dropwise while cooling the reaction flask 
in an ice-bath. The reaction mixture was stirred at room temperature for 2 h. Then, the 
solvent was evaporated and crude products were purified by column chromatography 
(SiO2, hexane/ethyl acetate, 1:1). Analytically pure samples were obtained after 
crystallization from an appropriate solvent. 
 
4.4.1. N-Trifluoroacetyl-N’-(tert-butoxycarbonyl)hydrazine (4a). Yield: 608 mg (89%), 
colorless crystals, m.p. 129–131 °C (Et2O/hexane), (lit. [10a], m.p. = 130–132 °C). 1H 
NMR (600 MHz, DMSO-d6): δ 1.43 (s, 9H, 3 CH3), 9.28 (s, 1H, NH), 11.23 (s, 1H, 
NH). 13C NMR (150 MHz, DMSO-d6): δ 28.4 (3 CH3), 80.6 (C(CH3)3), 116.3 (q, 1JC,F = 
286.5 Hz, CF3), 154.9 (C=O), 156.7 (q, 2JC,F = 35.1 Hz, CF3C=O). 19F NMR (565 MHz, 
DMSO-d6): δ –74.0 (s, 3F, CF3). IR (KBr): ν 3294s, 3196m, 3031m, 3000m, 2989m, 
2914w, 1741s, 1690vs, 1571w, 1506s, 1457w, 1400w, 1369m, 1247s, 1207vs, 1162s, 
1137s, 1052w, 1024w, 901w, 857w, 732m, 675w cm–1. ESI-(–)-MS: m/z 227 (100%, 
 10 
[M–1]–). Anal. calcd for C7H11F3N2O3: C, 36.85; H, 4.86; N, 12.28; found: C, 37.02; H, 
4.96; N, 12.30. 
 
4.4.2. N-Trifluoroacetyl-N’-(benzyloxycarbonyl)hydrazine (4b). Yield: 605 mg (77%), 
colorless crystals, m.p. 109–111 °C (Et2O/hexane). 1H NMR (600 MHz, DMSO-d6): δ 
5.14 (s, 2H, CH2), 7.35–7.39 (m, 5 arom. CH), 9.75 (br. s, 1H, NH), 11.44 (br. s, 1H, 
NH). 13C NMR (150 MHz, DMSO-d6): δ 66.9 (CH2), 116.3 (q, 1JC,F = 286.5 Hz, CF3), 
128.4, 128.6, 128.9 (5 arom. CH), 136.7 (1 arom. C), 155.8 (C=O), 156.7 (q, 2JC,F = 35.8 
Hz, CF3C=O). 19F NMR (565 MHz, DMSO-d6): δ –74.0 (s, 3F, CF3). IR (KBr): ν 
3335m, 3268m, 3227m, 3041m, 2968w, 2915w, 1761s, 1713s, 1689s, 1549m, 1511m, 
1357w, 1243vs, 1209vs, 1158s, 1046w, 969w, 746m, 697m cm–1. ESI-(–)-MS: m/z 261 
(100%, [M–1]–). Anal. calcd for C10H9F3N2O3: C, 45.81; H, 3.46; N, 10.68; found: C, 
45.67; H, 3.56; N, 10.85. 
 
4.4.3. N-Difluoroacetyl-N’-(benzyloxycarbonyl)hydrazine (4c). Yield: 682 mg (93%), 
colorless crystals, m.p. 116–117 °C (Et2O/hexane). 1H NMR (600 MHz, DMSO-d6): δ 
5.13 (s, 2H, CH2), 6.37 (t, 2JH,F = 52.9 Hz, 1H, CHF2), 7.35–7.39 (m, 5 arom. CH), 9.51 
(s, 1H, NH), 10.74 (s, 1H, NH). 13C NMR (150 MHz, DMSO-d6): δ 66.7 (CH2), 108.6 
(t, 1JC,F = 245.4 Hz, CHF2), 128.4, 128.5, 128.9 (5 arom. CH), 136.9 (1 arom. C), 156.0 
(C=O), 162.3 (t, 2JC,F = 25.0 Hz, CHF2C=O). 19F NMR (565 MHz, DMSO-d6): δ –126.8 
(d, 2JH,F = 52.9 Hz, 2F, CHF2). IR (KBr): ν 3316m, 3091w, 3064w, 3040w, 3017w, 
2996w, 2965w, 2903w, 1739m, 1683m, 1546m, 1506m, 1464w, 1384w, 1358w, 1257m, 
1205w, 1106w, 1056m, 960w, 750m, 701m, 580m cm–1. ESI-(+)-MS: m/z 267 (100%, 
[M+23]+), ESI-(–)-MS: m/z 243 (100%, [M–1]–). Anal. calcd for C10H10F2N2O3: C, 
49.19; H, 4.13; N, 11.47; found: C, 49.32; H, 4.13; N, 11.60. 
 
4.5. Preparation of fluorinated acid hydrazides via hydrogenolysis of N-difluoroacetyl- 
and N-trifluoroacetyl-N’-(benzyloxycarbonyl)hydrazines and their reactions with 
isocyanates and isothiocyanates – General procedure 
 
A portion of the catalyst (10% Pd/C (60 mg)) was added to the solution of the CBz-
protected hydrazide (6a or 6b; 2.0 mmol) in anhydrous THF (~50 ml). Next, the 
reaction flask was equipped with a septum, a long syringe and a balloon filled with 
hydrogen. Progress of the reaction was monitored by TLC (SiO2, hexane/AcOEt 1:1), 
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and as soon as the reaction was finished, the solution was filtered through a Celite pad. 
Next, the appropriate isocyanate 5a–d or isothiocyanate 5e–h (2.2 mmol), was added 
dropwise to the filtrate while cooling the reaction flask in the ice-bath (~0o C). The 
mixture was stirred overnight at room temperature. After evaporation of the solvent, 
crude products were purified by column chromatography (SiO2, hexane with increasing 
amount of AcOEt 40–90%). Semicarbazides 6a–f and thiosemicarbazides 6g–j were 
obtained as amorphous solids by trituration with Et2O. 
 
4.5.1. N-Phenyl trifluoroacetic acid semicarbazide (6a). Yield: 436 mg (88%), colorless 
crystals, m.p. 176–178 °C. 1H NMR (600 MHz, DMSO-d6): δ 6.98–7.00 (m, 1 arom. 
CH), 7.26–7.29 (m, 2 arom. CH), 7.45–7.46 (m, 2 arom. CH), 8.44 (br. s, 1H, NH), 8.96 
(br. s, 1H, NH), 11.24 (br. s, 1H, NH). 13C NMR (150 MHz, DMSO-d6): δ 116.5 (q, 
1JC,F = 289.4 Hz, CF3), 119.1, 122.7, 129.1 (5 arom. CH), 139.8 (1 arom. C–NH), 154.7 
(C=O), 156.8 (q, 2JC,F = 34.8 Hz, CF3C=O). 19F NMR (565 MHz, DMSO-d6): δ –73. 6 
(s, 3F, CF3). IR (KBr): ν 3297s, 3057m, 2890w, 1727vs, 1667vs, 1608s, 1574s, 1558m, 
1360m, 1317m, 1303m, 1216s, 1189vs, 1165vs, 1128s, 1078w, 1044w, 1033w, 920m, 
857w, 745m, 695m, 633m, 581w cm–1. ESI-(+)-MS: m/z 248 (100%, [M+1]+); ESI-(–)-
MS: m/z 246 (100%, [M–1]–). HR-EI-MS: calcd. for C9H8F3N3O2+ (M+): m/z 
247.05686; found: m/z 247.05713. 
 
4.5.2. N-(4-Fluorophenyl) trifluoroacetic acid semicarbazide (6b). Yield: 483 mg 
(91%), colorless crystals, m.p. = 190–191 °C. 1H NMR (600 MHz, DMSO-d6): δ 7.10–
7.13 (m, 2 arom. CH), 7.45–7.48 (m, 2 arom. CH), 8.49 (br. s, 1H, NH), 9.04 (br. s, 1H, 
NH), 11.23 (br. s 1H, NH). 13C NMR (150 MHz, DMSO-d6): δ 115.6, 115.7 (4 arom. 
CH), 116.4 (q, 1JC,F = 286.6 Hz, CF3), 136.1 (1 arom. C–NH), 154.8 (C=O), 157.1 (q, 
2JC,F = 35.7 Hz, F3CC=O), 158.0 (d, 1JC,F = 237 Hz, 1 arom. C–F) ppm. 19F NMR (565 
MHz, DMSO-d6): δ –117.3 (s, 1F, CF), –73.7 (s, 3F, CF3). IR (KBr): ν 3378m, 3319m, 
3265m, 3227m, 3065w, 2908w, 1720m, 1690s, 1664s, 1620w, 1571s, 1514s, 1411w, 
1363w, 1277w, 1219s, 1198s, 1170s, 1124w, 1099w, 1053w, 1015w, 923w, 832w, 793w, 
739w, 635w cm–1. ESI-(+)-MS: m/z 266 (100%, [M+1]+); ESI-(–)-MS: m/z 264 (100%, 
[M–1]–). HR-EI-MS: calcd. for C9H7F4N3O2+ (M+): m/z 265.04744; found: m/z 
265.04734. 
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4.5.3. N-(4-Methoxyphenyl) trifluoroacetic acid semicarbazide (6c). Yield: 475 mg 
(86%), colorless crystals, m.p. = 186–188 °C. 1H NMR (600 MHz, DMSO-d6): δ 3.72 
(s, 3H, CH3), 6.85–6.88 (m, 2 arom. CH), 7.33–7.36 (m, 2 arom. CH), 8.36 (br. s, 1H, 
NH), 8.79 (br. s, 1H, NH), 11.18 (br. s, 1H, NH). 13C NMR (150 MHz, DMSO-d6): δ 
55.6 (OCH3), 114.4, 114.5, 120.4, 121.1 (4 arom. CH), 116.4 (q, 1JC, F = 286.6 Hz, CF3), 
132.7 (1 arom. C–NH), 155.0 (1 arom. C–OCH3), 155.2 (C=O), 157.0 (q, 2JC,F = 35.4 
Hz, CF3C=O). 19F NMR (565 MHz, DMSO-d6): δ –73.7 (s, 3F, CF3). IR (KBr): ν 
3289s, 3146w, 3088w, 3056w, 3008w, 2954w, 2914w, 2837w, 1728s, 1668vs, 1608s, 
1575s, 1540m, 1515s, 1465w, 144w, 1361w, 1304w, 1251s, 1218s, 1190s, 1173vs, 
1128s, 1104m, 1031m, 920m, 836m, 799w, 836m, 739m, 636m cm–1. ESI-(+)-MS: m/z 
278 (75%, [M+1]+), 300 (100%, [M+23]+), ESI-(–)-MS: m/z 276 (100%, [M–1]–). HR-
EI-MS: calcd. for C10H10F3N3O3+ (M+): m/z 277.06743; found: m/z 277.06731. 
 
4.5.4. N-Cyclohexyl trifluoroacetic acid semicarbazide (6d). Yield: 471 mg (93%), 
colorless crystals, m.p. = 151–152 °C. 1H NMR (600 MHz, DMSO-d6): δ 1.11–1.30, 
1.54–1.76 (2m 10H, 5 CH2), 3.39–3.40 (m, 1H, CH), 6.38 (br. s, 1H, NH), 7.99 (br. s, 
1H, NH), 11.02 (s, 1H, NH). 13C NMR (150 MHz, DMSO-d6): δ 25.0, 25.6, 33.3 (5 
CH2), 48.8 (CH), 116.4 (q, 1JC, F = 286.5 Hz, CF3), 156.5 (C=O), 156.9 (q, 2JC,F = 35.5 
Hz, CF3C=O). 19F NMR (565 MHz, DMSO-d6): δ –73.7 (s, 3F, CF3). IR (KBr): ν 
3331m, 3267m, 3116w, 3027w, 2935m, 2858m, 1748s, 1737m, 1675s, 1636m, 1589m, 
1551w, 1489w, 1465w, 1456w, 1358w, 1317w, 1253m, 1239m, 1204s, 1164s, 1133m, 
1078m, 1018w, 914w, 891w, 795w, 737m, 656w cm–1. ESI-(+)-MS: m/z 254 (25%, 
[M+1]+), 276 (100%, [M+23]+); ESI-(–)-MS: m/z 252 (100%, [M–1]–). HR-EI-MS: 
calcd. for C9H14F3N3O2+ (M+): m/z 253.10381; found: m/z 253.10283. 
 
4.5.5. N-Phenyl difluoroacetic acid semicarbazide (6e). Yield: 410 mg (90%), colorless 
crystals, m.p. = 172–174 °C. 1H NMR (600 MHz, DMSO-d6): δ 6.32 (t, 1JC,F = 52.1 Hz, 
CHF2), 6.96–6.98 (m, 1 arom. CH), 7.25–7.27 (m, 2 arom. CH), 7.43–7.45 (m, 2 arom. 
CH), 8.39 (br. s, 1H, NH), 8.89 (br. s, 1H, NH), 10.64 (br. s, 1H, NH). 13C NMR (150 
MHz, DMSO-d6):δ 108.4 (t, 1JC,F = 244.5 Hz, CHF2), 118.8, 122.2, 128.8 (5 arom. CH), 
139.0 (1 arom. C–NH), 154.7 (C=O), 161.9 (t, 2JC, F= 25.2Hz, CHF2C=O). 19F NMR 
(565 MHz, DMSO-d6): δ – 126.5 (d, 2JF,H = 52.1 Hz, 2F, CHF2). IR (KBr): ν 3366s, 
3300s, 3199s, 3099m, 3039m, 2926w, 2857w, 1946w, 1929w, 1739s, 1717vs, 1693vs, 
1653s, 1600vs, 1564s, 1498s, 1444s, 1383w, 1320m, 1254m, 1218m, 1174m, 1151w, 
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1109s, 973w, 906w, 837w, 745s, 692m, 645m cm–1. ESI-(+)-MS: m/z 252 
(100%,[M+23]+); ESI-(–)-MS: m/z 228 (100%, [M–1]–). HR-EI-MS: calcd. for 
C9H15F2N3O2+ (M+): m/z 229.06628; found: m/z 229.06638. 
 
4.5.6. N-Cyclohexyl difluoroacetic acid semicarbazide (6f). Yield: 442 mg (94%), 
colorless crystals, m.p. =178–179 °C. 1H NMR (600 MHz, DMSO-d6): δ 1.13–1.28, 
1.65–1.76 (2m, 10H, 5 CH2), 3.31–3.42 (m, CH), 6.26 (t, 1JC,F = 53.2 Hz, CHF2), 6.28 
(br. s, 1H, NH), 7.88 (br. s, 1H, NH), 10.44 (br. s, 1H, NH). 13C NMR (150 MHz, 
DMSO-d6): δ 25.0, 25.7, 33.4 (5 CH2), 48.6 (CH), 108.6 (t, 1JC,F = 244.2 Hz, CHF2), 
156. 8 (C=O), 162.0 (t, 2JC,F = 25.2 Hz, CHF2C=O). 19F NMR (565 MHz, DMSO-d6): δ 
–126.5 (d, 2JF,H = 53.2 Hz, 2F, CHF2). IR (KBr): ν 3391m, 3351s, 3231s, 3104w, 3038w, 
2935s, 2856m, 1731s, 1709s, 1656vs, 1564vs, 1464w, 1454m, 1399w, 1370w, 1346w, 
1320w, 1277w, 1258w, 1238m, 1190w, 1125s, 1095m, 1076m, 978w, 967w, 893w, 
845w, 824w, 773w, 670w, 639w cm–1. ESI-(+)-MS: m/z 236 (50%, [M+1]+), 258 (100%, 
[M+23]+); ESI-(–)-MS: m/z 234 (100%, [M–1]–). HR-EI-MS: calcd. for C9H15F2N3O2+ 
(M+): m/z 235.11323; found: m/z 235.11329. 
 
4.5.7. N-Phenyl trifluoroacetic acid thiosemicarbazide (6g). Yield: 405 mg (77%); 
colorless crystals, m.p. = 128–129 °C. 1H NMR (600 MHz, DMSO-d6): δ 7.18–7.46 (m, 
5 arom. CH), 9.75 (br. m, 2H, 2 NH), 11.52 (br. s, 1H, NH). 13C NMR (150 MHz, 
DMSO-d6): δ 116.8 (q, 1JC,F = 291.7 Hz, CF3), 125.6 (1 arom. C–NH), 128.7, 139.4 (5 
arom. CH), 155.8 (q, 2JC,F = 30.0 Hz, CF3C=O), 179.9 (C=S). 19F NMR (565 MHz, 
DMSO-d6): δ –73.6 (s, 3F, CF3). IR (KBr): ν 3310m, 3158m, 3034m, 2891w, 1735vs, 
1628w, 1594m, 1538s, 1520s, 1498m, 1487m, 1451m, 1418w, 1362w, 1270w, 1217s, 
1166vs, 1155vs, 1117m, 1029w, 1005w, 935w, 898w, 745m, 697m, 638w, 615w, 526m 
cm–1. ESI-(+)-MS: m/z 264 (75%, [M+1]+), 286 (100%, [M+23]+); ESI-(–)-MS: m/z 262 
(100%, [M–1]–). HR-EI-MS: calcd. for C9H8F3N3OS+ (M+): m/z 263.03402; found: m/z 
263.03415. 
 
4.5.8. N-(4-Fluorophenyl) trifluoroacetic acid thiosemicarbazide (6h). Yield: 415 mg 
(74%), colorless crystals, m.p. = 138–139 °C. 1H NMR (600 MHz, DMSO-d6): δ 7.17–
7.20 (m, 2 arom. CH), 7.45 (m, 2 arom. CH), 9.85 (br. m, 2H, 2 NH), 11.53 (br. s, 1H, 
NH). 13C NMR (150 MHz, DMSO-d6): δ 116.0, 115.5 (4 arom. CH), 116.9 (q, 1JC,F = 
289.5 Hz, CF3), 136.1 (1 arom. C–NH), 157.3 (q, 2JC,F = 35.7 Hz, F3CC=O), 158.1 (d, 
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1JC,F = 237.1 Hz, 1 arom. C–F) 178.1 (C=S) ppm. 19F NMR (565 MHz, DMSO-d6): δ –
117.3 (s, 1F, CF), –73.4 (s, 3F, CF3). IR (KBr): ν 3238m, 3148w, 3063m, 1726m, 
1616w, 1559m, 1518m, 1416w, 1362m, 1304w, 1249w, 1208m, 1191m, 1170m, 1126w, 
1097w, 918w, 830w, 803w, 743w, 691w cm–1. ESI-(+)-MS: m/z 282 (100%, [M+1]+); 
ESI-(–)-MS: m/z 280 (100%, [M–1]–). HR-EI-MS: calcd. for C9H7F4N3OS+ (M+): m/z 
281.02460; found: m/z 281.02429. 
 
4.5.9. N-(4-Methoxyphenyl) trifluoroacetic acid thiosemicarbazide (6i). Yield: 401 mg 
(68%), colorless crystals, m.p. = 140–141 °C. 1H NMR (600 MHz, DMSO-d6): δ 3.77 
(s, 3H, CH3), 6.93–6.94 (m, 2 arom. CH), 7.26–7.27 (m, 2 arom. CH), 9.73 (br. s, 1H, 
NH), 9.88 (br. s, 1H, NH), 11.47 (br. s, 1H, NH). 13C NMR (150 MHz, DMSO-d6): δ 
55.7 (OCH3), 114.0, 132.1 (4 arom. CH) 127.8 (1 arom. C–NH), 116.4 (q, 2JC,F = 286.5 
Hz, CF3), 156.8 (q, 2JC,F = 35.7 Hz, CF3C=O), 157.5 (1 arom. C–OCH3), 181.9 (C=S). 
19F NMR (565 MHz, DMSO-d6): δ –73.6 (s, 3F, CF3). IR (KBr): ν 3424w, 3214m, 
3046w, 2966w, 2943w, 2918w, 2845w, 1716m, 1613w, 1589w, 1545m, 1516m, 1469w, 
1357m, 1302w, 1240m, 1215m, 1187m, 1168m, 1130w, 1101w, 1028m, 925m, 841w, 
783w, 742w, 688w, 658w cm–1. ESI-(+)-MS: m/z 294 (100%, [M+1]+), ESI-(–)-MS: m/z 
292 (100%, [M–1]–). HR-EI-MS: calcd. for C10H10F3N3OS+ (M+): m/z 293.04458; 
found: m/z 293.04374. 
 
4.5.10. N-Phenyl difluoroacetic acid thiosemicarbazide (6j). Yield: 394 mg (80%), 
colorless crystals, m.p. = 143–144 °C. 1H NMR (600 MHz, DMSO-d6): δ 6.30 (t, 2JC,F = 
50.8 Hz, CHF2), 7.19–7.43 (m, 5 arom. CH), 9.79 (br. m, 2H, 2 NH), 10.91 (br. s, 1H, 
NH). 13C NMR (150 MHz, DMSO-d6): δ. 108.6 (t, 1JC,F = 244.8 Hz, CHF2), 125.8 (1 
arom. C–NH), 128.7, 139.4 (5 arom. CH), 162.3 (t, 2JC, F= 25.0 Hz, CHF2C=O), 181.4 
(C=S). 19F NMR (565 MHz, DMSO-d6): δ –126.9 (d, 2JF,H = 50.8 Hz, 2F, CHF2). IR 
(KBr): ν 3284m, 3163m, 3033m, 2886w, 1725s, 1592w, 1523s, 1500s, 1452m, 1374w, 
1335w, 1290w, 1241w, 1201m, 1150s, 1120m, 1090s, 1027w, 1004w, 970w, 935w, 
911w, 820w, 742m, 697s, 668w, 636w, 616w cm–1. ESI-(+)-MS: m/z 246 (50%, 
[M+1]+), 268 (100%, [M+23]+). HR-EI-MS: calcd. for C9H9F2N3OS+ (M+): m/z 
245.04344; found: m/z 245.03121. 
 
4.6. Cyclization of thiosemicarbazides 6g–j to 1,3,4-oxadiazoles 7a–d 
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Method A – General procedure. Dicyclohexylcarbodiimide (DCC, 305 mg, 1.48 mmol) 
was added to a solution of the appropriate thiosemicarbazide (6g–j) (1.0 mmol) in 
anhydrous THF (~15 ml). The mixture was heated at reflux for 9 h and then the solvent 
was evaporated. The obtained crude products were purified by column chromatography 
(SiO2, hexane/Et2O, 6:4). 
Method B – General procedure. Tosyl chloride (229 mg, 1.20 mmol) and Et3N (2.20 
mmol, 222 mg) were added to a solution of thiosemicarbazide 7g (263 mg, 1.0 mmol) in 
N-methylpyrrolidin-2-one (NMP, 8 ml). The mixture was stirred for 3 h at room 
temperature and after this time, H2O (~10 ml) and CH2Cl2 (15 ml) were added. The 
organic layer was separated and the aqueous layer was washed two times with 
dichloromethane (2×15 ml). The organic layers were combined, dried over anhydrous 
Na2SO4 and filtered. Next, the solvent was evaporated and the product was purified by 
column chromatography (SiO2, hexane/Et2O 6:4). 
 
4.6.1. 2-Phenylamino-5-trifluoromethyl-1,3,4-oxadiazole (7a). Yield: 210 mg (92 %) 
method A; 140 mg (61%) method B; colorless crystals, m.p. = 129–131 °C. 1H NMR 
(600 MHz, DMSO-d6): δ 7.08–7.10 (m, 1 arom. CH), 7.4–7.42 (m, 2 arom. CH), 7.6–
7.7 (m, 2 arom. CH), 11.1 (br. s, 1H, NH) ppm. 13C NMR (150 MHz, DMSO-d6): δ 
116.8 (q, 1JC, F= 268.1 Hz, CF3), 118.2, 123.4, 129.7 (5 arom. CH), 138.1 (C(5)), 147.9 
(q, 2JC,F = 42.9 Hz, CCF3), 161.7 (C(2)NHPh). 19F NMR (565 MHz, DMSO-d6): δ –64.6 
(s, 3F, CF3). IR (KBr): ν 3186 w, 3082w, 2996w, 2944w, 2879w, 1676s, 1603m, 1588m, 
1503m, 1407w, 1346w, 1333w, 1231w, 1210m, 1165m, 1142m, 1119m, 1058w, 1032w, 
968w, 890w, 729w, 749m, 688w, 627w cm–1. ESI-(+)-MS: m/z 230 (100%, [M+1]+); 
ESI-(–)-MS: m/z 228 (100%, [M–1]–). HR-EI-MS: calcd. for C9H6F3N3O+ (M+): m/z 
229.04630; found: m/z 229.04587. 
 
4.6.2. 2-[(4-Fluorophenyl)amino]-5-trifluoromethyl-1,3,4-oxadiazole (7b). Yield: 219 
mg (95%) method A; colorless crystals, m.p. = 147–149 °C. 1H NMR (600 MHz, 
DMSO-d6): δ 7.24–7.27 (m, 2 arom. CH), 7.58–7.61 (m, 2 arom. CH), 11.11 (br. s, 1H, 
NH).  13C NMR (150 MHz, DMSO-d6): δ 116.8 (q, 1JC, F= 268.0 Hz, CF3), 116.2, 116.3, 
119.8, 119.9 (4 arom. CH), 134.5 (C(5)), 147.9 (q, 2JC,F = 43.0 Hz, CCF3), 158.4 (d, 1JC, 
F= 238.0 Hz, 1 arom. C–F), 161.7 (C(2)NHC6H4F). 19F NMR (565 MHz, DMSO-d6): δ 
–120.2 (s, 1F, CF), –64.5 (s, 3F, CF3). IR (KBr): ν 3337w, 3191w, 3074w, 2998w, 
2945w, 2874w, 1679s, 1668s, 1607m, 1596m, 1511vs, 1441w, 1387m, 1328m, 1232s, 
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1164m, 1116s, 1057m, 968w, 830m, 750m cm–1. ESI-(+)-MS: m/z 248 (100%, [M+1]+). 
HR-EI-MS: calcd. for C9H5F4N3O+ (M+): m/z 247.03687; found: m/z 247.03693. 
 
4.6.3. 2-[(4-Methoxyphenyl)amino]-5-trifluoromethyl-1,3,4-oxadiazole (7c). Yield: 193 
mg (80%) method A; colorless crystals, m.p. 153–154 °C. 1H NMR (600 MHz, DMSO-
d6): δ 3.75 (s, 3H, OCH3), 6.98–6.99 (m, 2 arom. CH), 7.48–7.49 (m 2 arom. CH), 10.85 
(br. s, 1H, NH).  13C NMR (150 MHz, DMSO-d6): δ 55.7 (OCH3), 114.9, 119.9 (4 arom. 
CH), 116.8 (q, 1JC, F= 267.9 Hz, CF3), 131.2 (C(5)), 147.6 (q, 2JC,F = 42.7 Hz, CCF3), 
155.7 (1 arom. C–OCH3), 162.0 (C(2)NHC6H4OCH3). 19F NMR (565 MHz, DMSO-d6): 
δ –64.5 (s, 3F, CF3). IR (KBr): ν 3281m, 3131w, 3061w, 3008w, 2954w, 2920w, 2836w, 
1632vs, 1586s, 1540m, 1518s, 1457m, 1426m, 1383s, 1229s, 1171s, 1133s, 1060m, 
1034m, 987w, 831w cm–1. ESI-(+)- MS: m/z 260 (100%, [M+1]+). HR-EI-MS: calcd. for 
C10H8F3N3O2+ (M+): m/z 259.05686; found: m/z 259.05641. 
 
4.6.4. 2-Phenylamino-5-difluoromethyl-1,3,4-oxadiazole (7d). Yield: 160 mg (82%), 
method A; colorless crystals, m.p. 157–158 °C. 1H NMR (600 MHz, DMSO-d6): δ 7.07 
(t, 2JH,F = 7.2 Hz 1H, CHF2), 7.38–7.40 (m, 3 arom. CH), 7.57–7.59 (m, 2 arom. CH), 
10.87 (br. s, 1H, NH). 13C NMR (150 MHz, DMSO-d6): δ 107.1 (t, 1JC, F= 235.2 Hz, 
CHF2), 117.9, 123.0, 129.6 (5 arom. CH), 138.5 (C(5)), 153.2 (t, 2JC,F = 28.6 Hz, 
CCHF2), 161.7 (C(2)NHPh). 19F NMR (565 MHz, DMSO-d6): δ–119.9 (d, 2JF,H = 51.4 
Hz, 2F, CHF2). IR (KBr): ν 3329w, 3252w, 3189w, 3073w, 3023m, 2955m, 2882m, 
2748w, 2660w, 1668s, 1602s, 1589s, 1504s, 1479m, 1394w, 1375m, 1355m, 1292m, 
1230w, 1108m, 1050s, 987m, 885w, 838m, 748s, 730m, 686m cm–1. ESI-(+)-MS: m/z 
274 (100%, [M+23]+); ESI-(–)-MS: m/z 250 (100%, [M–1]–). HR-EI-MS: calcd. for 
C9H7F2N3O+ (M+): m/z 211.05572; found: m/z 211.05605. 
 
4.7. Cyclization of thiosemicarbazides 6g,i to 1,2,4-triazole-3-thiones 8a,b – General 
procedure 
An aqueous solution of NaOH (2%, ~2 ml) and an appropriate thiosemicarbazide (6g,i) 
was heated at reflux for 3 h. Next, the reaction mixture was neutralized with acetic acid, 
the product was extracted with AcOEt (3 25ml), and the combined organic layers were 
dried over anhydrous Na2SO4. After evaporation of the solvent, the crude products were 
purified by column chromatograpy (SiO2, hexane/AcOEt 6:4). 
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4.7.1. 2,4-Dihydro-4-phenyl-5-trifluoromethyl-3H-1,2,4-triazole-3-thione (8a) [15]. 
Yield: 42 mg (34%), pale-yellow crystals, m.p. = 170–172 °C. 1H NMR (600 MHz, 
DMSO-d6): δ 7.50–7.51 (m, 2 arom. CH), 7.59–7.60 (m, 3 arom. CH), 14.69 (br. s, 1H, 
NH). 13C NMR (150 MHz, DMSO-d6): δ 117.1 (q, 1JC, F= 269.1 Hz, CF3), 128.9, 129.9, 
130.8 (4 arom. CH), 132.9 (1 arom. C), 140.7 (q, 2JC,F = 39.9 Hz, CCF3), 171.3 (C=S). 
19F NMR (565 MHz, DMSO-d6): δ – 62.7 (s, 3F, CF3). IR (KBr): ν 3145m, 3091m, 
3033m, 2911m, 2853m, 2741m, 1597m, 1498s, 1474s, 1446s, 1458s, 1344w, 1277s, 
1238s, 1219s, 1176s, 1149s, 1093m, 1036m, 984m, 775m cm–1. ESI-(+)-MS: m/z 246 
(100%, [M+1]+); ESI-(–)-MS: m/z 244 (100%, [M–1]–). HR-EI-MS: calcd. for 
C9H6F3N3S+ (M+): m/z 245.02345; found: m/z 245.02339. 
 
4.7.2. 5-Difluoromethyl-2,4-dihydro-4-phenyl-3H-1,2,4-triazole-3-thione (8b) [15]. 
Yield: 41 mg (36%), colorless crystals, m.p. = 187–189 °C. 1H NMR (600 MHz, 
DMSO-d6): δ 7.04 (t, 2JH,F = 51.6 Hz, 1H, CHF2), 7.46–7.47 (m, 2 arom. CH), 7.57–7.62 
(m 3 arom. CH), 14.41 (br. s, 1H, NH). 13C NMR (150 MHz, DMSO-d6): δ 107.8 (t, 
1JC,F = 235.9 Hz, CHF2), 128.7, 129.8, 130.4 (5 arom. CH), 133.3 (1 arom. C), 144.9 (t, 
2JC,F = 27.9 Hz CHF2C), 170.5 (C=S). 19F NMR (565 MHz, DMSO-d6): δ –119.2 (d, 
2JF,H = 50.8 Hz, 2F, CHF2). IR (KBr): ν 3249w, 3149w, 3089m, 3037m, 2999w, 2902m, 
2848m, 2745m, 1594w, 1541m, 1497s, 1487s, 1435m, 1340w, 1323m, 1270s, 1229m, 
1193w, 1176w, 1126m, 1077s, 1056s, 1015w, 823m, 776m, 738w, 724w, 690m cm–1. 
ESI-(+)-MS: m/z 228 (100%, [M+1]+); ESI-(–)-MS: m/z 226 (100%, [M–1]–). HR-EI-
MS: calcd. for C9H7F2N3S+ (M+): m/z 227.03287; found: m/z 227.03285. 
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